ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Press Release Eupraxia Pharmaceuticals Announces Filing of Preliminary Base Shelf Prospectus
December 14, 2021Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery platform technology, announced today that it has filed and obtained a receipt for a preliminary short form... -
Eupraxia Pharmaceuticals Inc. Announces $10 Million Convertible Debt Agreement with Silicon Valley Bank and Conversion of $6.0 Million pre-IPO Debt
June 22, 2021Eupraxia Pharmaceuticals Inc. today announced that it has entered into a contingent convertible debt agreement (the "Agreement") with Silicon Valley Bank ("SVB") and concurrently drew down in full the $10 million principal amount under the Agreement.
Pharma Sources Insight January 2025
